← SynDRA
EMIGLITATE
SynDRA canonical compound SYN0032052 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | GAA |
|---|
| Mechanism of action | alpha glucoside inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- alpha glucoside inhibitor
Drug classes
Cross-references
Synonyms
- Emiglitato
- BAY-O-1248
- BAY-o 1248
- Emiglitatum
- PF8AB2IBUM
- DTXCID2028725
- RefChem:920927
- N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxynojirimycin
- N-(beta-(4-ethoxycarbonyl)phenoxy)ethyl-1-desoxy-nojirimycin
- NCGC00183836-01
- Emiglitatum [Latin]
- Emiglitato [Spanish]
- Emiglitate [INN:BAN]
- UNII-PF8AB2IBUM
- EINECS 279-613-2
- MKC-542
- Emiglitate (JAN/INN)
- EMIGLITATE [INN]
- EMIGLITATE [JAN]
- EMIGLITATE [MART.]
- SCHEMBL26909
- orb1707336
- CHEBI:230574
- NWWORXYTJRPSMC-QKPAOTATSA-N
- Tox21_113276
- MFCD00867465
- AKOS027378704
- CS-6655
- DA-63174
- HY-16194
- MS-25552
- CAS-80879-63-6
- NS00011753
- D09779
- G12756
- T15215
Look up EMIGLITATE in the interactive SynDRA portal →